B&

Barer & Son Capital

North America, New Jersey, United States, Mendham

Description

Barer & Son Capital is an investment firm

Investor Profile

Barer & Son Capital has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (50%)
  • Series B (25%)
  • Convertible Note (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Therapeutics
  • Biopharma
  • Health Care
  • Medical
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Barer & Son Capital frequently co-invest with?

HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Rapha Capital Management
North America, New York, United States, Florida
Co-Investments: 2
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Terra Magnum Capital Partners
Asia, Beijing, China, Changyang
Co-Investments: 1
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 1
Salem Partners
North America, California, United States, Los Angeles
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
PC
North America, North Carolina, United States, Greensboro
Co-Investments: 2

What are some of recent deals done by Barer & Son Capital?

AsclepiX Therapeutics

Baltimore, Maryland, United States

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Series AJun 24, 2020
Amount Raised: $35,000,000
Viela Bio

Gaithersburg, Maryland, United States

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.

BiopharmaBiotechnologyHealth DiagnosticsMedicalWellness
Series BJun 18, 2019
Amount Raised: $75,000,000
AsclepiX Therapeutics

Baltimore, Maryland, United States

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Convertible NoteNov 13, 2018
Amount Raised: $5,000,000
NexImmune

Gaithersburg, Maryland, United States

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

BiopharmaBiotechnologyTherapeutics
Series AJan 2, 2018
Amount Raised: $23,000,000